levetiracetam 1000 mg oral tablet
1 INDICATIONS AND USAGE Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) Levetiracetam is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy ( 1.2 ) Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy ( 1.3 ) 1.1 Partial-Onset Seizures Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam is indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures Levetiracetam is indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.
taro pharmaceuticals u.s.a., inc.
OVAL WHITE LVT 1000
LVT 1000 OVAL WHITE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
LEVETIRACETAM Tablets USP, 250 mg are blue, film coated caplet shape tablets, scored on one side, engraved with "LVT" on the left of the score and "250" on the right, and "TARO" on the other side. They are supplied in white HDPE bottles containing: 30 Tablets (NDC 51672-4141-6); 120 Tablets (NDC 51672-4141-1); 1000 Tablets (NDC 51672-4141-3); and Blisters of 100 (10 × 10) (NDC 51672-4141-0).
LEVETIRACETAM Tablets USP, 500 mg are yellow, film coated caplet shape tablets, scored on one side, engraved with "LVT" on the left of the score and "500" on the right, and "TARO" on the other side. They are supplied in white HDPE bottles containing: 30 Tablets (NDC 51672-4142-6); 120 Tablets (NDC 51672-4142-1); 1000 Tablets (NDC 51672-4142-3); and Blisters of 100 (10 × 10) (NDC 51672-4142-0).
LEVETIRACETAM Tablets USP, 750 mg are peach, film coated caplet shape tablets, scored on one side, engraved with "LVT" on the left of the score and "750" on the right, and "TARO" on the other side. They are supplied in white HDPE bottles containing: 30 Tablets (NDC 51672-4143-6); 120 Tablets (NDC 51672-4143-1); 1000 Tablets (NDC 51672-4143-3); and Blisters of 100 (10 × 10) (NDC 51672-4143-0).
LEVETIRACETAM Tablets USP, 1000 mg are white to off-white, film coated caplet shaped tablets, scored on one side, engraved with "LVT" on the left of the score and "1000" on the right, and "TARO" on the other side. They are supplied in white HDPE bottles containing: 30 Tablets (NDC 51672-4137-6); 60 Tablets (NDC 51672-4137-4); and 750 Tablets (NDC 51672-4137-8).
LEVETIRACETAM Oral Solution USP, 100 mg/mL is a clear to yellowish, grape-flavored liquid. It is supplied in HDPE bottles: 100 mL (NDC 51672-4136-7); 473 mL (NDC 51672-4136-9); and 3785 mL (NDC 51672-4136-0). 16.2 Storage Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
More pills like OVAL LVT 1000